London – October 7, 2016 – The Financial Times highlighted Cooley’s cutting-edge client work in its 11th annual FT Innovative Lawyers Europe report. The firm also received placement in the FT Top 50 Business of Law list.
For the category Legal Expertise: Creating New Collaborations, Cooley was highly commended for its work advising on the formation of a groundbreaking joint venture called Apollo Therapeutics, a research and technology collaboration between Big Pharma and some of the technology transfer organization of some of the UK’s leading universities.
In the FT’s Innovation in Technology and Data Analytics category, Cooley was commended for “leveraging the firm’s US expertise, resources and technology to help a UK client, IT consultancy Ciber, do fast and affordable e-discovery for a litigation case.”
“It’s great to have been recognized by the Financial Times in its European innovative lawyers report for the second time,” said Justin Stock, managing partner of Cooley’s London office. “Our January 2015 UK launch was a seminal moment for the firm and we are proud of the partnerships we have made with clients that are innovating in Europe and beyond.”
FT Innovative Lawyers Report is one of the top legal rankings and analysis in Europe, assessing lawyers on their innovation both for clients and in their own businesses. Cooley is also regularly featured in the FT Innovative Lawyers North America.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.